Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Transl Psychiatry ; 9(1): 84, 2019 02 11.
Article in English | MEDLINE | ID: mdl-30745561

ABSTRACT

Efavirenz is recommended as a preferred first-line drug for women of childbearing potential living with human immunodeficiency virus. Efavirenz is known for its central nervous system side effects, which are partly mediated by serotonergic actions. The neurotransmitter serotonin exerts neurotrophic effects during neurodevelopment and antenatal exposure to serotonergic agents has been linked to developmental delay. Although the teratogenic risks of efavirenz appear to be minimal, data on long-term developmental effects remain scarce. Here, we aimed to investigate the short- and long-term behavioral and neurodevelopmental effects of perinatal efavirenz exposure. We treated pregnant rats from gestation day 1 until postnatal day 7 with efavirenz (100 mg/kg) or vehicle. We measured behavioral outcomes in male offspring during the first 3 postnatal weeks, adolescence and adulthood, and conducted brain immunohistochemistry analyses after sacrifice. Perinatal efavirenz exposure resulted in reduced body weight and delayed reflex and motor development. During adulthood, we observed a decrease in the total number of cells and mature neurons in the motor cortex, as well as an increase in the number of Caspase-3-positive cells and serotonergic fibers. Together, our data show a developmental delay and persistent changes in the brain motor cortex of rats exposed to efavirenz perinatally. Because over 1 million children born annually are exposed to antiretroviral therapy, our findings underline the need for clinical studies on long-term neurodevelopmental outcomes of perinatal exposure to efavirenz.


Subject(s)
Benzoxazines/pharmacology , Developmental Disabilities/chemically induced , Neurons/cytology , Prenatal Exposure Delayed Effects/chemically induced , Alkynes , Animals , Body Weight/drug effects , Cyclopropanes , Female , HIV Infections/drug therapy , Male , Motor Activity/drug effects , Motor Cortex/cytology , Motor Cortex/pathology , Neurons/drug effects , Pregnancy , Rats , Rats, Wistar , Reflex, Startle , Serotonin/metabolism
2.
Mol Neurobiol ; 56(2): 1405-1420, 2019 Feb.
Article in English | MEDLINE | ID: mdl-29948943

ABSTRACT

Proper development of the medial prefrontal cortex (mPFC), crucial for correct cognitive functioning, requires projections from, among others, the serotonergic (5-HT) and catecholaminergic systems, but it is unclear how these systems influence each other during development. Here, we describe the parallel development of the 5-HT and catecholaminergic prefrontal projection systems in rat and demonstrate a close engagement of both systems in the proximity of Cajal-Retzius cells. We further show that in the absence of the 5-HT transporter (5-HTT), not only the developing 5-HT but also the catecholaminergic system, including their projections towards the mPFC, are affected. In addition, the layer identity of the mPFC neurons and reelin-positive interneuron number and integration are altered in the absence of the 5-HTT. Together, our data demonstrate a functional interplay between the developing mPFC 5-HT and catecholaminergic systems, and call for a holistic approach in studying neurotransmitter systems-specific developmental consequences for adult behavior, to eventually allow the design of better treatment strategies for neuropsychiatric disorders.


Subject(s)
Prefrontal Cortex/metabolism , Raphe Nuclei/metabolism , Serotonin/metabolism , Signal Transduction/physiology , Animals , Male , Neurons/metabolism , Neurons/pathology , Neurotransmitter Agents/metabolism , Prefrontal Cortex/growth & development , Prefrontal Cortex/pathology , Raphe Nuclei/pathology , Rats, Wistar , Reelin Protein
SELECTION OF CITATIONS
SEARCH DETAIL
...